Servier in the U.S. is a Boston-based, commercial-stage biopharmaceutical company launched by Servier Group in 2018. As a privately held organization, Servier is uniquely positioned to advance cutting-edge science, tackle underserved therapeutic areas and make patients the focus of every strategic decision. The Director, US Emerging Portfolio Strategy (US EPS) Neurology reports to the Executive Director of US EPS, who has responsibility for the assessment of the developing pipeline and external (BD) opportunities in neurology within the US EPS and Corporate Business Office (CBO) team. The Director US Emerging Portfolio Strategy will be responsible for helping to ensure that the business is best positioned to deliver on its strategy and business priorities for emerging neurology products and lifecycle management programs. This person will lead collaboratively through influence and direct, as appropriate, cross-functional project teams and be a trusted advisor/leader.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director